AMLYPAVE

Swiss trademark · 845630 · Word mark · In force

Register entry

Registration number
845630
Application number
04481/2026
Status
In force
Type
Word mark
Filed
Apr 18, 2024
Registered
Mar 17, 2026
Published
Mar 17, 2026
Protected until
Apr 18, 2034
Remarks
Transformation de l'enregistrement international n° 1659393 (art. 46a LPM).
Source
Swissreg

Goods and services

Pharmaceuticals

Préparations pharmaceutiques pour le traitement de maladies et troubles inflammatoires, maladies et troubles auto-immuns, maladies et troubles métaboliques, maladies et troubles liés à l'agrégation de protéines, maladies et troubles neurodégénératifs.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 26, 2026

    Corrected

    Filing date
    07.04.2022 → 18.04.2024
    Expiry date
    07.04.2032 → 18.04.2034
    Priorities
    11.10.2021 US (removed)

    Published in Swissreg on 26.03.2026

  2. Mar 17, 2026

    Registered

    Published in Swissreg on 17.03.2026

Parties

Holder

Alexion Pharmaceuticals, Inc.

121 Seaport Boulevard, 02210 Boston, Massachusetts, US

Agent

Dennemeyer AG

Bahnhofstrasse 23,, 6300 Zug

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.